Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05973513 · ClinicalTrials.gov registry record
Open Trial of Biofeedback for Respiratory Symptoms
A clinical trial of Shortness of Breath/Dyspnea, sponsored by University of California, Los Angeles.
- Active
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT05973513: Active study of Shortness of Breath/Dyspnea, sponsored by University of California, Los Angeles.
NCT05973513 is a study of Shortness of Breath/Dyspnea that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05973513, a study of Shortness of Breath/Dyspnea, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Biofeedback is a therapeutic paradigm that teaches patients how to gain awareness and control over previously unrecognized sympathetic changes such as body temperature, blood pressure, and heart rate. We propose to use a six session biofeedback protocol that includes heart-rate variability (HRV) biofeedback, respiration/relaxation training, and body temperature control to treat patients with unaddressed respiratory symptoms (e.g. shortness of breath) who are under the care of pulmonologists and have not responded to traditional biomedical approaches (e.g. inhalers, pulmonary rehab, etc.).
Primary Outcome
Improvement in self-rated depressive sx on the PHQ-9
Conditions Studied
Study Locations (1)
California
- Natacha Emerson - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2028-07-31 |
What the registry record for NCT05973513 still lists
NCT05973513 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 1 condition, with Shortness of Breath/Dyspnea appearing as the primary indexed condition, and to 0 interventions.
NCT05973513 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05973513 about?
NCT05973513 is a clinical study titled "Open Trial of Biofeedback for Respiratory Symptoms". Biofeedback is a therapeutic paradigm that teaches patients how to gain awareness and control over previously unrecognized sympathetic changes such as body temperature, blood pressure, and heart rate. We propose to use a six session biofeedback protocol that includes heart-rate variability (HRV) bio...
What is the current status of trial NCT05973513?
This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2021-08-01. Estimated completion is 2028-07-31.
What conditions does trial NCT05973513 study?
This clinical trial studies the following conditions: Shortness of Breath/Dyspnea.
Who is sponsoring clinical trial NCT05973513?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05973513 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI